Siddharth J. Advant, PhD

Latest from Siddharth J. Advant, PhD

Emerging Strategies for Drug-Product Comparability and Process Validation: Part 2 — Validation, Legacy Products, and Lifecycle Management
CMC Forums
Emerging Strategies for Drug-Product Comparability and Process Validation: Part 2 — Validation, Legacy Products, and Lifecycle ManagementEmerging Strategies for Drug-Product Comparability and Process Validation: Part 2 — Validation, Legacy Products, and Lifecycle Management
byZahra Shahrokh, Andrew Weiskopfand 7 more
Apr 16, 2021
Emerging Strategies for Drug Product Comparability and Process Validation: Part 1 — Analytical Tools and Drug Product Comparability
CMC Forums
Emerging Strategies for Drug Product Comparability and Process Validation: Part 1 — Analytical Tools and Drug Product ComparabilityEmerging Strategies for Drug Product Comparability and Process Validation: Part 1 — Analytical Tools and Drug Product Comparability
byZahra Shahrokh, Andrew Weiskopfand 7 more
Mar 9, 2021

All from Siddharth J. Advant, PhD

Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and Analytics
CMC Forums
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and Analytics
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and Analytics
Dec 17, 2020
+8
byAnthony Mire-Sluis, Sarah Kennettand 8 more
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream Strategies
CMC Forums
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream Strategies
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream Strategies
Oct 29, 2020
+7
byAnthony Mire-Sluis, Sarah Kennettand 7 more
CMC Strategy Forum on Combination Products for Biopharmaceuticals: Emerging Trends in Development, GMPs, and Regulatory Expectations
CMC Forums
CMC Strategy Forum on Combination Products for Biopharmaceuticals: Emerging Trends in Development, GMPs, and Regulatory Expectations
CMC Strategy Forum on Combination Products for Biopharmaceuticals: Emerging Trends in Development, GMPs, and Regulatory Expectations
Mar 20, 2017
+6
bySiddharth J. Advant, PhD, Jee Chungand 6 more
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
CMC Forums
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
Apr 12, 2016
+18
byCheryl Scott, Siddharth J. Advant, PhDand 18 more
Effective Management of Contract Organizations: Keeping the Product Pipeline Moving, Compliant, and Available
Economics
Effective Management of Contract Organizations: Keeping the Product Pipeline Moving, Compliant, and Available
Effective Management of Contract Organizations: Keeping the Product Pipeline Moving, Compliant, and Available
Oct 15, 2015
+7
byAnthony Mire-Sluis, Julia Edwardsand 7 more
New Paradigms for Process Validation: A Practical Approach logo in a gray background | New Paradigms for Process Validation: A Practical Approach
CMC Forums
New Paradigms for Process Validation: A Practical Approach
New Paradigms for Process Validation: A Practical Approach
Apr 14, 2015
+11
byAnthony Mire- Sluis, Vijay Chiruvoluand 11 more
Multiproduct Facility Design and Control for Biologics: Challenges and Considerations logo in a gray background | Multiproduct Facility Design and Control for Biologics: Challenges and Considerations
CMC Forums
Multiproduct Facility Design and Control for Biologics: Challenges and Considerations
Multiproduct Facility Design and Control for Biologics: Challenges and Considerations
Apr 14, 2015
+7
byBo Chi, Julia Edwardsand 7 more
The Rise of Biopharmaceutical Outsourcing to Indian CDMOs
Contract Services
The Rise of Biopharmaceutical Outsourcing to Indian CDMOs
The Rise of Biopharmaceutical Outsourcing to Indian CDMOs
Jun 1, 2014
bySiddharth J. Advant, PhD, Jaby Jacob, PhD
New Paradigms for Process Validation logo in a gray background | New Paradigms for Process Validation
Cell Line Development
New Paradigms for Process Validation
New Paradigms for Process Validation
Oct 1, 2013
+11
byAnthony Mire- Sluis, Vijay Chiruvoluand 11 more
Multiproduct Facility Design and Control for Biologics logo in a gray background | Multiproduct Facility Design and Control for Biologics
MAb
Multiproduct Facility Design and Control for Biologics
Multiproduct Facility Design and Control for Biologics
Dec 1, 2012
+7
byBo Chi, Julia Edwardsand 7 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024